Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells.

Antioxidants (Basel) · 2019 · PMC6826379 · PMID 31652503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

The effect of Sorafenib alone was slightly significant in SNU423 cells but was markedly enhanced by Trx1 silencing.

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.